Market Research Logo

U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 202

U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020

In vitro diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for the diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases, thus helping physicians to diagnose and treat diseases promptly and effectively. The most important trend witnessed recently in the U.S. IVD industry is the trend of self-testing as opposed to patients visiting hospitals. This is a key factor driving the growth of point-of-care testing, as patients prefer self-testing to avoid hospital visits. IVD tests have a significant role in the prevention, monitoring, diagnosis, and treatment of diseases. Common IVD tests include blood tests for glucose, tests for detection of electrolytes (calcium, sodium, and potassium), liver enzymes, and drug tests.

The U.S. IVD market is projected to reach USD 25.99 billion by 2020 at a CAGR of 4.7% from 2015 to 2020. The rising incidence of chronic and infectious diseases, rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing demand for automated instruments, and automation in laboratories are key factors driving the IVD market in the U.S. In this report, the market is segmented by product & service, technology, application, end user, and region.

The U.S. IVD product & services market is broadly segmented into reagents, instruments, services, and data management system/software. The instruments market is further segmented into fully automated instruments, semi-automated instruments, and other instruments. The fully automated instruments segment accounted for the largest share of the U.S IVD instruments market in 2014. The increasing number and complexity of tests, coupled with a shortage in laboratory staff, is driving the greater adoption of fully automated instruments in laboratories.

On the basis of end user, the U.S. IVD market is segmented into hospital laboratories, clinical/independent laboratories, and others. In 2014, the hospital laboratories segment accounted for the largest share of the U.S. IVD market in the U.S. The high inpatient flow and ancillary outpatient flow in hospitals, growing prevalence of chronic and infectious diseases, and increasing number of accredited laboratories are key factors driving market growth in this end-user segment.

The major players in the U.S. IVD market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Johnson & Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), QIAGEN N.V. (Netherlands), Alere Inc. (U.S.), Ortho-Clinical Diagnostics Inc. (U.S.), and bioMérieux (France).

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on product portfolios offered by top players in the U.S. IVD market. The report analyzes the U.S. IVD market by product, technology, end user, and application across all regions
Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the U.S. IVD market
Market Development: Comprehensive information on the lucrative emerging markets by product, technology, end user, application, and region
Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the U.S. IVD market
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of leading players in the U.S. IVD market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • GROWTH POTENTIAL OF THE U.S. IN VITRO DIAGNOSTICS MARKET
    • U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER (2014)
    • U.S. IN VITRO DIAGNOSTICS MARKET, REGIONAL MIX
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • BY PRODUCT
      • BY TECHNOLOGY
      • BY APPLICATION
      • BY END USER
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCREASED INCIDENCE OF CHRONIC DISEASES AND RAPID GROWTH IN GERIATRIC POPULATION WILL DRIVE THE MARKET GROWTH
      • RESTRAINTS
        • Table UNFAVORABLE REIMBURSEMENT AND RISING HEALTHCARE COSTS TO RESTRAIN MARKET GROWTH
      • OPPORTUNITIES
        • Table CONDITION SPECIFIC MARKERS, AN AREA OF OPPORTUNITY
      • CHALLENGES
        • Table STRINGENT & UNCERTAIN REGULATIONS, A KEY CHALLENGE FOR THE IVD MARKET
  • U.S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table U.S. IVD MARKET SIZE, BY PRODUCT & SERVICE, 2013-2020 (USD MILLION)
      • Table U.S.: IVD MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • REAGENTS
      • Table U.S. IVD REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • INSTRUMENTS
      • Table U.S. IVD INSTRUMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.S. IVD INSTRUMENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
      • FULLY AUTOMATED INSTRUMENTS
      • SEMI-AUTOMATED INSTRUMENTS
      • OTHERS
    • DATA MANAGEMENT SOFTWARE
      • Table U.S. IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • SERVICES
      • Table U.S. IVD SERVICES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • U.S. IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table U.S. IVD MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
    • CLINICAL CHEMISTRY
      • Table U.S. CLINICAL CHEMISTRY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • IMMUNOCHEMISTRY/IMMUNOASSAYS
      • Table U.S. IMMUNOCHEMISTRY/IMMUNOASSYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • MICROBIOLOGY
      • Table U.S. MICROBIOLOGY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • MOLECULAR DIAGNOSTICS (MDX)
      • Table U.S. MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • HEMATOLOGY
      • Table U.S. HEMATOLOGY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • COAGULATION/HEMOSTASIS
      • Table U.S. COAGULATION/HEMOSTASIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • OTHER IVD TECHNOLOGIES
      • Table U.S. OTHER IVD TECHNOLOGIES MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • U.S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table U.S. IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • INFECTIOUS DISEASES
      • Table INFECTIOUS DISEASE INCIDENCE IN THE U.S., 2008-2012
      • Table HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVALENCE IN THE U.S., BY REGION
      • Table U.S. IVD MARKET SIZE, FOR INFECTIOUS DISEASES BY END USER, 2013-2020 (USD MILLION)
    • DIABETES
      • Table DIABETES INCIDENCE IN THE U.S., BY REGION, 2008-2012
      • Table U.S. IVD MARKET SIZE, FOR DIABETES BY END USER, 2013-2020 (USD MILLION)
    • ONCOLOGY/CANCER
      • Table CANCER INCIDENCE RATE IN THE U.S., BY REGION (PER 100,000 INDIVIDUALS), 2008-2012
      • Table U.S. IVD MARKET SIZE, FOR ONCOLOGY/CANCER BY END USER, 2013-2020 (USD MILLION)
    • CARDIOVASCULAR DISORDERS
      • Table U.S. IVD MARKET SIZE, FOR CARDIOVASCULAR DISORDERS BY END USER, 2013-2020 (USD MILLION)
    • ENDOCRINE DISORDERS
      • Table OBESITY INCIDENCE RATE IN THE U.S., BY REGION (PER 100,000 INDIVIDUALS), 2008-2012
      • Table U.S. IVD MARKET SIZE, FOR ENDOCRINE DISORDERS BY END USER, 2013-2020 (USD MILLION)
    • AUTOIMMUNE DISEASES
      • Table ARTHRITIS INCIDENCE IN THE U.S., BY REGION, 2011 & 2013
      • Table U.S. IVD MARKET SIZE, FOR AUTOIMMUNE DISEASES BY END USER, 2013-2020 (USD MILLION)
    • BONE & MINERAL-RELATED DISEASES
      • Table U.S. IVD MARKET SIZE, FOR BONE & MINERAL-RELATED DISEASES BY END USER, 2013-2020 (USD MILLION)
    • PULMONARY DISEASES
      • Table ASTHMA PREVALENCE IN THE U.S., BY AGE, 2007-2011
      • Table U.S. IVD MARKET SIZE, FOR PULMONARY DISEASES BY END USER, 2013-2020 (USD MILLION)
    • OTHER APPLICATIONS
      • Table U.S. IVD MARKET SIZE, FOR OTHER APPLICATIONS BY END USER, 2013-2020 (USD MILLION)
  • U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table U.S.: IVD MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • HOSPITAL LABORATORIES
      • Table U.S.: IVD MARKET SIZE FOR HOSPITAL LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
      • Table U.S.: IVD MARKET SIZE FOR HOSPITAL LABORATORIES, BY APPLICATION, 2013-2020 (USD MILLION)
    • CLINICAL/INDEPENDENT LABORATORIES
      • Table U.S.: IVD MARKET SIZE FOR CLINICAL LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
      • Table U.S.: IVD MARKET SIZE FOR CLINICAL LABORATORIES, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table U.S.: IVD MARKET SIZE FOR CLINICAL LABORATORIES, BY LABORATORY SIZE, 2013-2020 (USD MILLION)
      • LARGE LABORATORIES/REFERENCE LABORATORIES
      • MEDIUM-SIZED LABORATORIES
      • SMALL LABORATORIES
    • OTHER END USERS
      • Table U.S.: IVD MARKET SIZE FOR OTHER END USER, BY REGION, 2013-2020 (USD MILLION)
      • Table U.S.: IVD MARKET SIZE FOR OTHER END USERS, BY APPLICATION, 2013-2020 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
      • Table GROWTH STRATEGY MATRIX, 2012-2015
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES, 2014-2015
      • COLLABORATIONS, AGREEMENTS, & PARTNERSHIPS
        • Table COLLABORATIONS, AGREEMENTS, & PARTNERSHIPS, 2014-2016
      • APPROVALS
        • Table APPROVALS, 2015
      • MERGERS & ACQUISITIONS
        • Table MERGERS & ACQUISITIONS, 2014-2016
      • OTHERS
        • Table OTHERS, 2014-2015
  • COMPANY PROFILES
    • ABBOTT LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • JOHNSON AND JOHNSON
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIEMENS HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BIOMÉRIEUX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • SYSMEX CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • SERVICES & SUPPORT
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report